NYSE:JNJ Johnson & Johnson Q3 2026 Earnings Report $253.57 -2.46 (-0.96%) As of 11:00 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Johnson & Johnson EPS ResultsActual EPSN/AConsensus EPS $2.78Beat/MissN/AOne Year Ago EPSN/AJohnson & Johnson Revenue ResultsActual RevenueN/AExpected Revenue$25.36 billionBeat/MissN/AYoY Revenue GrowthN/AJohnson & Johnson Announcement DetailsQuarterQ3 2026Date10/13/2026TimeBefore Market OpensConference Call DateTuesday, October 13, 2026Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Johnson & Johnson Earnings HeadlinesLooking for a Dividend Stock That Can Weather a Downturn? Start With Johnson & Johnson.1 hour ago | fool.comMunicipal Bonds vs Dividend Stocks: Which Income Actually Keeps More of Your Money?October 4 at 3:13 PM | 247wallst.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.October 5 at 1:00 AM | Profits Run (Ad)Johnson & Johnson (JNJ) Reports Sustained Phase 3 Skin Clearance For ICOTYDEOctober 3 at 5:27 PM | finance.yahoo.comJohnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasisOctober 2 at 1:52 PM | marketscreener.comMJ&J's Innovative Medicine Segment in Q3: Key Growth Drivers to WatchOctober 2 at 1:52 PM | finance.yahoo.comSee More Johnson & Johnson Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Johnson & Johnson? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Johnson & Johnson and other key companies, straight to your email. Email Address About Johnson & JohnsonJohnson & Johnson (NYSE:JNJ) (NYSE: JNJ) is a global healthcare company that develops, manufactures and markets products through two primary business segments: Innovative Medicine and MedTech. Its operations serve patients, healthcare professionals and consumers in markets around the world. The Innovative Medicine segment focuses on prescription medicines in areas including immunology, oncology, neuroscience, cardiovascular and metabolic disease, infectious diseases, and pulmonary hypertension. The MedTech segment develops technologies and products used in surgery, orthopaedics, cardiovascular care, vision care and other medical specialties. Founded in 1886 and headquartered in New Brunswick, New Jersey, Johnson & Johnson has a long history in healthcare and formerly operated a substantial consumer health business. That consumer health business was separated into Kenvue in 2023, allowing Johnson & Johnson to focus primarily on pharmaceutical and medical technology operations. The company is led by Chairman and Chief Executive Officer Joaquin Duato.View Johnson & Johnson ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?Time to Nibble on MCD Stock After it Enters Oversold Territory?Liberty Energy’s AI Power Push Has Wall Street DividedMcCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the Test Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
